Skip to main content
. 2019 Jun 3;20(11):2724. doi: 10.3390/ijms20112724

Figure 3.

Figure 3

Changes in glycemic status and lipid metabolism by CDAA diet feeding and LPS administration. (A) Plasma glucose levels after 0, 15, 30, 60, 120 min for oral glucose tolerance test (OGTT) at the end of experiment. (B) The values of Glucose-AUC (area under the blood concentration-time curve) in the experimental group. The value of AUC was calculated as the area under the curve of plasma glucose level at OGTT. (C) Plasma insulin levels in the experimental groups at sacrifice (120 min. after oral glucose intake). (D) The multiplicated values of plasma glucose and insulin level in the experimental groups at sacrifice (120 min. after oral glucose intake). (E–G) Relative mRNA expression levels of Srebf1, Fas, Acc1 (E), Ppara (F) and Pparg (G) in the liver of experimental mice. The mRNA expression levels were measured by quantitative RT–PCR (qRT–PCR), and Gapdh was used as internal control for qRT–PCR (E–G). Quantitative values are indicated as ratios to the values of CSAA-LPS (−) group (E–G). Data are mean ± SD (n = 6). a: p < 0.05 compared with CSAA-LPS (−), b: p < 0.05 compared with CSAA-LPS (+), c: p < 0.05 compared with CDAA-LPS (−).